financetom
Business
financetom
/
Business
/
AMD Stock Is Rising Tuesday: Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AMD Stock Is Rising Tuesday: Here's Why
Oct 14, 2025 6:38 AM

Advanced Micro Devices Inc ( AMD ) shares are trading higher Tuesday after the company announced that Oracle Corp ( ORCL ) Cloud will deploy 50,000 of its AI chips.

What To Know: AMD and Oracle announced a major expansion of their long-standing collaboration to help customers significantly scale AI capabilities. Oracle Cloud Infrastructure will become a launch partner for the first publicly available AI supercluster powered by AMD Instinct MI450 Series GPUs.

Oracle Cloud Infrastructure is expected to deploy an initial 50,000 GPUs starting in the third quarter of 2026 and then expanding in 2027 and beyond.

Oracle Cloud Infrastructure’s planned new AI superclusters will be powered by AMD’s Helios rack architecture, which is designed to deliver maximum performance, scalability and efficiency for large-scale AI training and inference.

“Through our decade-long collaboration with AMD—from EPYC to AMD Instinct accelerators—we’re continuing to deliver the best price-performance, open, secure, and scalable cloud foundation in partnership with AMD to meet customer needs for this next era of AI,” said Mahesh Thiagarajan, executive vice president, Oracle Cloud Infrastructure.

AMD Analysis: AMD stock shows strong momentum with a Benzinga Edge ranking of 89.51. The recent price action indicates higher highs and higher lows, confirming an uptrend.

The RSI is calculated at 70.25, indicating that the stock is nearing overbought territory, which could signal a potential pullback. MACD lines are bullish, with the MACD at 2.15 and the signal line at 1.85, showing positive momentum but also hinting at potential consolidation.

AMD shares are trading about 9.9% below 52-week highs, and are sitting approximately 29.2% above the 50-day moving average.

AMD Price Action: AMD stock was up 1.46% at $219.57 at the time of publication on Tuesday, according to Benzinga Pro.

Read Next:

JPMorgan CEO Jamie Dimon Calls US Economy ‘Resilient’, But Warns Of ‘Trade Uncertainty, Sticky Inflation’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RTX Unit Raytheon Awarded $515 Million Contract for Radar Support for US Navy, Germany
RTX Unit Raytheon Awarded $515 Million Contract for Radar Support for US Navy, Germany
Jun 3, 2026
09:27 AM EDT, 06/03/2026 (MT Newswires) -- RTX (RTX) said Wednesday that its Raytheon unit has been awarded a $515 million contract from the US Navy for the SPY-6 family of radars. The company said the sole source award contract is a follow-on to the Integration and Production Support contract, which it won in June of last year, and includes...
CytomX Therapeutics Expands Cancer Therapy Partnership With Regeneron; Shares Rise
CytomX Therapeutics Expands Cancer Therapy Partnership With Regeneron; Shares Rise
Jun 3, 2026
09:21 AM EDT, 06/03/2026 (MT Newswires) -- CytomX Therapeutics ( CTMX ) said Wednesday it is expanding a licensing agreement with Regeneron Pharmaceuticals ( REGN ) to develop conditionally activated bispecific cancer treatments. CytomX said it will receive a $37 million target nomination payment for two newly chosen development programs. Regeneron holds the right to select up to six more...
Arcus Biosciences Partners With Bristol Myers Squibb to Develop Kidney Cancer Treatment
Arcus Biosciences Partners With Bristol Myers Squibb to Develop Kidney Cancer Treatment
Jun 3, 2026
09:20 AM EDT, 06/03/2026 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Wednesday it is partnering with Bristol Myers Squibb ( BMY ) to develop a treatment regimen for kidney cancer. Arcus said that under the agreement, it will supply its casdatifan drug, which will be evaluated in a Bristol Myers Squibb ( BMY )-sponsored phase 1/2 clinical trial....
Eagle Plains And Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, Saskatchewan
Eagle Plains And Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, Saskatchewan
Jun 3, 2026
09:23 AM EDT, 06/03/2026 (MT Newswires) -- Eagle Plains Resources ( EGPLF ) with partner, Xcite Uranium ( XRIUF ) provided initial geophysical results for its 4502 hectares Beaver River Uranium Project, on Wednesday. Strong correlations exist between areas of known uranium mineralization at the VIC and COMBINED zones with trends of anomalous conductivity, the companies said. The Calculated Vertical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved